Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Although world is not on track to end AIDS by 2030 but it is no less than a miracle when we take into account the scientific ...

About 2.5 million take PrEP, WHO said. More than 39,000 U.S. residents were diagnosed with HIV in 2023, according to the Centers for Disease Control and Prevention.

Late last year, the Department of Health warned that the number of Filipinos infected with Human Immunodeficiency Virus (HIV) might reach half a million by 2030 unless preventive measures and ...

Also Read: Cocktail of flu, HIV drugs appears to help fight coronavirus: Thai doctors Drugs to prevent HIV transmission, known as pre-exposure prophylaxis or PrEP, have existed for more than a decade.

In the 1990s, Thailand, under the leadership of then-Cabinet member Mechai Viravaidya, launched an intensive public information campaign on HIV/AIDS prevention. This included mandatory one-minute AIDS ...

For example, in Thailand, a programme serving over half of all PrEP users, saw 47% of clients discontinuing within 12 months, according to the Institute of HIV Research and Innovation (IHRI).